Basic Information
CVasThera is a French biopharmaceutical manufacturer specializing in the research of novel therapies for cardiovascular and intestinal diseases. The company is currently developing the CVT120165 candidate drug for the treatment of Crohn's disease.
CVASTHERA pharmaceutical
France
15~50 people
January 01, 2019
bruno.le.grand@cvasthera.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios